HRP940458B1 - New bis-naphtalimides for the treatment of canser - Google Patents

New bis-naphtalimides for the treatment of canser

Info

Publication number
HRP940458B1
HRP940458B1 HR08/108,949A HRP940458A HRP940458B1 HR P940458 B1 HRP940458 B1 HR P940458B1 HR P940458 A HRP940458 A HR P940458A HR P940458 B1 HRP940458 B1 HR P940458B1
Authority
HR
Croatia
Prior art keywords
treatment
naphtalimides
canser
new bis
formula
Prior art date
Application number
HR08/108,949A
Other languages
English (en)
Inventor
Gerhard Keilhauer
Cynthia Romerdahl
Miguel Fernandez Brana
Xiao-Dong Quian
Peter Bosquet
Jose Maria Castellano Berlanga
Marina Moran Moset
Maria Jesus Perez De Vega
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HRP940458A2 publication Critical patent/HRP940458A2/hr
Publication of HRP940458B1 publication Critical patent/HRP940458B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR08/108,949A 1993-08-18 1994-08-11 New bis-naphtalimides for the treatment of canser HRP940458B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10894993A 1993-08-18 1993-08-18

Publications (2)

Publication Number Publication Date
HRP940458A2 HRP940458A2 (en) 1997-06-30
HRP940458B1 true HRP940458B1 (en) 2000-02-29

Family

ID=22324990

Family Applications (1)

Application Number Title Priority Date Filing Date
HR08/108,949A HRP940458B1 (en) 1993-08-18 1994-08-11 New bis-naphtalimides for the treatment of canser

Country Status (28)

Country Link
US (3) US5616589A (de)
EP (1) EP0714387B1 (de)
JP (1) JPH09501662A (de)
KR (1) KR960703863A (de)
CN (1) CN1039414C (de)
AT (1) ATE166647T1 (de)
AU (1) AU677696B2 (de)
BR (2) BR9407257A (de)
CA (1) CA2169059A1 (de)
CZ (1) CZ34296A3 (de)
DE (1) DE69410614T2 (de)
DK (1) DK0714387T3 (de)
ES (1) ES2116612T3 (de)
FI (1) FI960658A7 (de)
HR (1) HRP940458B1 (de)
HU (1) HU219232B (de)
IL (1) IL110460A (de)
NO (1) NO305554B1 (de)
NZ (1) NZ271374A (de)
PH (1) PH31395A (de)
PL (1) PL313078A1 (de)
RU (1) RU2138484C1 (de)
SG (1) SG64906A1 (de)
SI (1) SI9420053A (de)
TW (1) TW408112B (de)
UA (1) UA42733C2 (de)
WO (1) WO1995005365A1 (de)
ZA (1) ZA946196B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703089A (en) * 1994-04-28 1997-12-30 Knoll Aktiengesellschaft Dihydrodibenzisoquinolinediones
AU728523C (en) * 1996-10-21 2001-08-09 Nps Pharmaceuticals, Inc. Neurotrophin antagonist compositions
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
WO2000055166A1 (en) 1999-03-16 2000-09-21 Regents Of The University Of California Glycosylated polyamines
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US6468990B1 (en) * 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
AU2001240054B2 (en) * 2000-03-07 2005-08-11 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 1,8-Naphthalimide Imidazo[4,5,1-de]acridones with Anti-Tumor Activity
CA2586320A1 (en) 2003-11-05 2005-05-19 Photobiomed Corporation Bonding tissues and cross-linking proteins with naphthalimide compounds
BRPI0510719A (pt) * 2004-05-05 2007-11-20 Unibioscreen Sa derivados de naftalimida, composição farmacêutica, uso e método de preparação dos mesmos
JP4993645B2 (ja) 2004-12-01 2012-08-08 ジェネンテック， インコーポレイテッド 抗体薬剤結合体および方法
US20070134243A1 (en) * 2004-12-01 2007-06-14 Gazzard Lewis J Antibody drug conjugates and methods
US7947839B2 (en) 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
WO2007030939A2 (en) 2005-09-15 2007-03-22 Painceptor Pharma Corporation Methods of modulating neurotrophin-mediated activity
WO2009089537A2 (en) 2008-01-11 2009-07-16 Northwestern University Anti-cancer compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3535496A1 (de) * 1985-10-04 1987-04-16 Bayer Ag Verfahren zur fluoreszenzloeschung und neue kationische naphthalin-peri-dicarbonsaeureimid-derivate
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
US5086052A (en) * 1987-07-17 1992-02-04 Abbott Laboratories Substituted 1,4,5,6-tetrahydro-2H-pyridazin-3-one and -3-thione compounds having lipoxygenase inhibitory activity
US5086059A (en) * 1990-06-07 1992-02-04 Du Pont Merck Pharmaceutical Company Bis-naphthalimides as anticancer agents
US5206249A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
JPH07501822A (ja) * 1991-12-11 1995-02-23 デュポン・ファーマシュウティカルズ・カンパニー 抗癌剤として有用な高度に水溶性のビス−ナフタルイミド
DE4232739A1 (de) * 1992-09-30 1994-03-31 Knoll Ag Neue asymmetrisch substituierte bis-Naphthalimide

Also Published As

Publication number Publication date
CZ34296A3 (en) 1996-08-14
EP0714387A1 (de) 1996-06-05
FI960658L (fi) 1996-02-14
NO960632L (no) 1996-02-16
NZ271374A (en) 1997-05-26
HUT73529A (en) 1996-08-28
NO960632D0 (no) 1996-02-16
SI9420053A (en) 1996-08-31
UA42733C2 (uk) 2001-11-15
AU677696B2 (en) 1997-05-01
US5789418A (en) 1998-08-04
BR1100143A (pt) 2000-03-14
CN1132506A (zh) 1996-10-02
IL110460A (en) 2001-01-11
CA2169059A1 (en) 1995-02-23
ES2116612T3 (es) 1998-07-16
DK0714387T3 (da) 1998-10-12
US5981753A (en) 1999-11-09
HU219232B (en) 2001-03-28
FI960658A0 (fi) 1996-02-14
ATE166647T1 (de) 1998-06-15
DE69410614D1 (de) 1998-07-02
DE69410614T2 (de) 1998-09-24
JPH09501662A (ja) 1997-02-18
KR960703863A (ko) 1996-08-31
PH31395A (en) 1998-10-29
ZA946196B (en) 1996-02-19
WO1995005365A1 (en) 1995-02-23
US5616589A (en) 1997-04-01
TW408112B (en) 2000-10-11
IL110460A0 (en) 1994-10-21
FI960658A7 (fi) 1996-02-14
RU2138484C1 (ru) 1999-09-27
BR9407257A (pt) 1996-09-24
SG64906A1 (en) 1999-05-25
HRP940458A2 (en) 1997-06-30
EP0714387B1 (de) 1998-05-27
AU7498494A (en) 1995-03-14
HU9600360D0 (en) 1996-04-29
PL313078A1 (en) 1996-05-27
CN1039414C (zh) 1998-08-05
NO305554B1 (no) 1999-06-21

Similar Documents

Publication Publication Date Title
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
AU2110892A (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
AU2125192A (en) New naphthylethlylureas and naphthylethylthioureas, process for the preparation thereof, and pharmaceutical compositions containing them
NZ237023A (en) 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
TW261616B (de)
SG64906A1 (en) New bis-naphthalimides for the treatment of cancer
MX9708696A (es) Cefalosporinas antibacterianas.
IL100266A0 (en) Fluorine compounds
TW252979B (de)
TW224461B (de)
ZA941196B (en) Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
AU4700993A (en) Diphosphates of catecholamines and pharmaceutical compositions containing them
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20010811

Year of fee payment: 8

PBON Lapse due to non-payment of renewal fee

Effective date: 20020812